ExpressGraft-Antineoplastic

N/A

Report date: 2025/01/26 19:33:18

Base Information

Drug NameExpressGraft-Antineoplastic
Drug Alias Namecell-based gene therapy (Stratatech)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionInterleukin-12 receptor stimulants
TargetsInterleukin-12 receptor
Therapy Area/IndicationsSkin Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStratatech Corp
China Registration ClassN/A

Develop Information

Active CompaniesStratatech Corp
Inactive CompaniesN/A
Active IndicationsSkin Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A